ARTICLE | Company News
Aventis' Lovenox gets additional indication
November 20, 2000 8:00 AM UTC
The FDA granted marketing approval for AVE's Lovenox enoxaparin low molecular weight heparin (LMWH) to prevent deep vein thrombosis (DVT) in patients at risk for thromboembolic complications due to se...